Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Sports Act. Living

Sec. Women in Sport

This article is part of the Research TopicOptimizing Women's Health through Exercise Prescription and Physiological Assessments across Life StagesView all 5 articles

Menstrual cycle or hormonal contraceptive related symptoms in elite female athletes from retrospective self-questionnaires and daily monitoring: impact on well-being and objective performance metrics

Provisionally accepted
Nolwenn  BADIERNolwenn BADIER1*Marine  DupuitMarine Dupuit1Tom  ChassardTom Chassard1Kilian  BarlierKilian Barlier1Alice  LafitteAlice Lafitte1Guillaume  SaulièreGuillaume Saulière1Lidia  DelrieuLidia Delrieu1Jean-François  ToussaintJean-François Toussaint1,2Juliana  AnteroJuliana Antero1
  • 1EA7329 Institut de Recherche BioMédical et d'Epidémiologie du Sport (IRMES), Paris, France
  • 2Hopital Hotel-Dieu de Paris, Paris, France

The final, formatted version of the article will be published soon.

Introduction: Negative menstrual cycle–related symptoms have been shown to perceptually impact well-being, as well as training and competition performance, yet they are rarely daily monitored over extended periods. The aim is to compare menstrual cycle (MC) and hormonal contraception (HC) related symptoms reported through retrospective and daily questionnaires in elite female athletes and to assess their association with well-being and performance metrics. Methods: Data were collected from 108 elite female athletes across seven sports over 554 full cycles. Participants completed a retrospective questionnaire on regular symptoms and provided daily prospective entries for 6 months (n = 16,491) about their symptoms, sleep, fitness and mood. Symptom reporting methods were compared, differences in symptom frequency across cycle phases were analyzed, and associations between symptom count and well-being were explored. Performance metrics were collected for sports providing objective data and analyzed comparing training with versus without reported symptoms. Results: Athletes reported more symptoms retrospectively than in daily questionnaires. Mood swings, tiredness, and pelvic pain were the most common retrospective symptoms, while bloating, tiredness, and pelvic pain were most frequent in daily entries. MC athletes reported more symptoms than HC users in both methods. According to the daily follow-up, symptoms were more frequent during menstruation and the prebleeding phase for MC athletes and the break phase for HC users. A significant negative correlation was observed between symptoms and well-being indicators. In football players, high-speed running distance significantly declined on symptomatic days. Conclusion: Retrospective questionnaires shows a greater symptom prevalence than daily monitoring. Symptoms, more frequent during bleeding phases, negatively impacted athletes' well-being and also high-speed running performance for football players. These findings highlight the importance of individualized monitoring and tailored interventions to optimize athlete health, well-being, and performance.

Keywords: Menstrual Cycle, Athletes, Survey & Questionnaire, Monitoring, Athletic Performance, Menstrual symptoms

Received: 26 Aug 2025; Accepted: 13 Nov 2025.

Copyright: © 2025 BADIER, Dupuit, Chassard, Barlier, Lafitte, Saulière, Delrieu, Toussaint and Antero. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nolwenn BADIER, nolwenn.badier@insep.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.